All articles by Miranda Mclaren

Understanding the current and future state of complex health data protection laws

The recent proliferation of digital health has led to data privacy concerns around the collection of sensitive personal health information (PHI). Pharmaceutical Technology looks at key regulations designed to protect consumers in the US and Europe.

Advancing parenteral packaging production for the future of pharmaceuticals

In this video interview, Dirk Borghs, CEO Datwyler Healthcare Solutions, talks through pharma’s constantly rising quality demands and the need for FirstLine® manufacturing.

Understanding the role of recombinant insulin in cell culture systems: What the studies say 

Abacus Medicine Pharma Services and Laboratoires CTRS extend partnership to improve access to Orphacol® in Spain

Container Closure Integrity Testing (CCIT): How to get started with deterministic methods

With reproducible and predictable results, deterministic test methods represent the most reliable form of container closure integrity testing. But with multiple methods to choose from, making the transition can feel like a big leap. Here, we share how to evaluate and implement new CCIT systems.

Aseptic lyophilisation: Opportunities to improve quality and process monitoring with mass spectrometry

Mass spectrometry is one of the most versatile technologies you can integrate in lyophilisation operations, enabling detection of silicone oil and external air leaks while optimising process analysis.

Quality first: How pharma can meet injectables demand while staying compliant

Abacus Medicine Pharma Services and AddMedica sign partnership agreement for the distribution of Siklos® in Benelux

How to control the freeze drying process in demanding conditions

Robust pressure gauges are an essential component of a repeatable freeze drying process, enabling manufacturers to preserve products with consistent quality levels every cycle.

Rare Disease Day: Why raising awareness is essential for a fairer future

This Rare Disease Day, we look at the role increased awareness and improved pharmaceutical market conditions can play in closing the treatment inequality gap for rare disease patients.